LONDON BROKER RATINGS: UBS cuts Antofagasta and Eurowag
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 211.70p on 02-02-2026 at 17:20:08 |
|---|---|
| Change | -6.50p -2.98% |
| Buy | 211.30p |
| Sell | 211.00p |
| Last Trade: | Sell 1,744.00 at 212.2261p |
| Day's Volume: | 3,243,347 |
| Last Close: | 211.70p |
| Open: | 216.80p |
| ISIN: | GB00B3MBS747 |
| Day's Range | 202.90p - 217.80p |
| 52wk Range: | 166.00p - 397.70p |
| Market Capitalisation: | £1.76b |
| VWAP: | 209.9335p |
| Shares in Issue: | 829.02m |
Ocado (OCDO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 1,744 | 212.2261p | Ordinary |
16:49:06 - 02-Feb-26 |
| Sell* | 1,192,669 | 211.70p | Uncrossing Trade |
16:35:20 - 02-Feb-26 |
| Sell* | 26 | 211.00p | Automatic Execution |
16:29:55 - 02-Feb-26 |
| Sell* | 187 | 211.10p | Automatic Execution |
16:29:37 - 02-Feb-26 |
| Sell* | 300 | 211.10p | Automatic Execution |
16:29:37 - 02-Feb-26 |
| Sell* | 23 | 211.10p | Automatic Execution |
16:29:37 - 02-Feb-26 |
| Sell* | 335 | 211.10p | Automatic Execution |
16:29:37 - 02-Feb-26 |
| Sell* | 300 | 211.30p | Automatic Execution |
16:29:35 - 02-Feb-26 |
| Sell* | 91 | 211.30p | Automatic Execution |
16:29:35 - 02-Feb-26 |
| Buy* | 91 | 211.50p | Automatic Execution |
16:29:35 - 02-Feb-26 |
Ocado (OCDO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th Jan 2026 7:00 am | RNS | Update on Sobeys Partnership |
| 28th Jan 2026 4:26 pm | RNS | Holding(s) in Company |
| 27th Jan 2026 4:57 pm | RNS | Block Listing Interim Review |
| 22nd Jan 2026 3:07 pm | RNS | Holding(s) in Company |
| 20th Jan 2026 3:25 pm | RNS | Holding(s) in Company |
| 16th Jan 2026 2:06 pm | RNS | Director/PDMR Shareholding |
| 13th Jan 2026 7:00 am | RNS | Holding(s) in Company |
| 9th Jan 2026 7:00 am | RNS | Holding(s) in Company |
| 2nd Jan 2026 10:46 am | RNS | Total Voting Rights |
| 30th Dec 2025 7:00 am | RNS | Exclusivity with International Partners |